Search Results

You are looking at 1 - 10 of 13 items for

  • Author: W. J. Visser x
  • Refine by access: All content x
Clear All Modify Search
W. J. DE GREEF
Search for other papers by W. J. DE GREEF in
Google Scholar
PubMed
Close
and
T. J. VISSER
Search for other papers by T. J. VISSER in
Google Scholar
PubMed
Close

The changes in adenohypophysial and hypothalamic content and in hypothalamic release of dopamine and thyrotrophin-releasing hormone (TRH) into the hypophysial portal system during the suckling-induced release of prolactin were investigated. An increase in peripheral plasma levels of prolactin was induced by mammary nerve stimulation in urethane-anaesthetized and by suckling in unanaesthetized lactating rats. In the unanaesthetized rat, suckling caused a decrease of dopamine levels in hypothalamus and adenohypophysis and a short-lasting small increase in hypothalamic TRH. Mammary nerve stimulation induced a transient decrease in dopamine levels and an increase in TRH levels in hypophysial stalk blood. To assess the significance of the observed changes in dopamine and TRH levels for prolactin release, these changes in dopamine and TRH were mimicked in lactating rats anaesthetized with urethane and pretreated with α-methyl-p-tyrosine (AMpT, a competitive inhibitor of catecholamine synthesis). Reducing hypothalamic dopamine secretion by treatment with AMpT increased peripheral plasma levels of prolactin from 15 to 477 ng/ml; an infusion with dopamine, resulting in plasma levels similar to those measured in hypophysial stalk plasma, reduced plasma levels of prolactin to 127 ng/ml. Neither a 50% reduction in dopamine infusion rate for 15 min nor administration of 100 ng TRH caused an appreciable change in plasma prolactin levels. However, when dopamine infusion was reduced by 50% for 15 min just before TRH was injected, then an increase in plasma levels of prolactin from 172 to 492 ng/ml was observed. Thus, the effectiveness of TRH in releasing prolactin in the lactating rat was enhanced when a transient decrease of dopamine levels occurred before treatment with TRH. It is concluded that the changes observed in dopamine and TRH levels in hypophysial stalk blood are involved in the suckling-induced prolactin release in an important manner.

Restricted access
W. J. de Greef
Search for other papers by W. J. de Greef in
Google Scholar
PubMed
Close
,
W. Klootwijk
Search for other papers by W. Klootwijk in
Google Scholar
PubMed
Close
,
B. Karels
Search for other papers by B. Karels in
Google Scholar
PubMed
Close
, and
T. J. Visser
Search for other papers by T. J. Visser in
Google Scholar
PubMed
Close

ABSTRACT

The changes in hypothalamic release of dopamine and thyrotrophin-releasing hormone (TRH) into the hypophysial portal vascular system during an oestrogen-stimulated surge of prolactin in ovariectomized rats were investigated.

A single injection of 5 μg oestradiol benzoate resulted in a reliable increase in the plasma levels of prolactin during the afternoon 3 days later. Anaesthesia did not block this afternoon surge of prolactin, although its magnitude was only half of that of unanaesthetized rats. Before and during this surge, hypophysial stalk blood was collected into methanol to analyse the hypothalamic release of dopamine and TRH. Immunoreactive TRH in these methanolic extracts eluted as a single peak with the same retention time as authentic TRH on reverse-phase high performance liquid chromatography. In comparison to the morning values, levels of dopamine decreased and those of TRH increased in hypophysial stalk blood by 50 and 240% respectively. These data indicate that hypothalamic dopamine and TRH may be involved in the afternoon surge of prolactin.

Daily treatment with parachlorophenylalanine, an inhibitor of serotonin synthesis, reduced the hypothalamic release of TRH by 50%, but did not prevent the afternoon surge of prolactin and TRH induced by oestradiol benzoate.

J. Endocr. (1985) 105, 107–112

Restricted access
Stefan Groeneweg Department of Internal Medicine and Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Stefan Groeneweg in
Google Scholar
PubMed
Close
,
Robin P Peeters Department of Internal Medicine and Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Robin P Peeters in
Google Scholar
PubMed
Close
,
Theo J Visser Department of Internal Medicine and Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Theo J Visser in
Google Scholar
PubMed
Close
, and
W Edward Visser Department of Internal Medicine and Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by W Edward Visser in
Google Scholar
PubMed
Close

Thyroid hormone (TH) is crucial for development and metabolism of many tissues. The physiological relevance and therapeutic potential of TH analogs have gained attention in the field for many years. In particular, the relevance and use of 3,3′,5-triiodothyroacetic acid (Triac, TA3) has been explored over the last decades. Although TA3 closely resembles the bioactive hormone T3, differences in transmembrane transport and receptor isoform-specific transcriptional activation potency exist. For these reasons, the application of TA3 as a treatment for resistance to TH (RTH) syndromes, especially MCT8 deficiency, is topic of ongoing research. This review is a summary of all currently available literature about the formation, metabolism, action and therapeutic applications of TA3.

Free access
T. J. VISSER
Search for other papers by T. J. VISSER in
Google Scholar
PubMed
Close
,
C. J. BUURMAN
Search for other papers by C. J. BUURMAN in
Google Scholar
PubMed
Close
,
W. H. L. HACKENG
Search for other papers by W. H. L. HACKENG in
Google Scholar
PubMed
Close
, and
J. C. BIRKENHÄGER
Search for other papers by J. C. BIRKENHÄGER in
Google Scholar
PubMed
Close

Department of Internal Medicine III and Clinical Endocrinology, Medical Faculty, Erasmus University, Rotterdam, and * Laboratory ofEndocrinological Chemistry, Municipal Hospital 'Bergweg', Rotterdam, The Netherlands

(Received 2 June 1975)

The availability of synthetic human parathyroid hormone (hPTH) fragments (Andreatta, Hartmann, Jöhl, Kamber, Maier, Riniker, Rittel & Sieber, 1973; Tregear, Van Rietschoten, Greene, Niall, Keutmann, Parsons, O'Riordan & Potts, 1974) has enabled the production of region specific antibodies and thus the development of region specific radioimmunoassays (RIA). This is particularly meaningful with respect to the heterogeneity of immunoreactive forms of PTH in the circulation (Arnaud, Goldsmith, Bordier, Sizemore, Larsen & Gilkinson, 1974). The peptides were synthesized according to the sequences proposed for the first 34 amino acids by Brewer, Fairwell, Ronan, Sizemore & Arnaud (1972) (referred to as 1–34 hPTH-B) and Niall, Sauer, Jacobs, Keutmann, Segre, O'Riordan, Aurbach & Potts (1974) (1–34 hPTH-N), which differ in positions 22, 28 and 30.

Two

Restricted access
J M M Rondeel
Search for other papers by J M M Rondeel in
Google Scholar
PubMed
Close
,
W Klootwijk
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Close
,
E Linkels
Search for other papers by E Linkels in
Google Scholar
PubMed
Close
,
G A C van Haasteren
Search for other papers by G A C van Haasteren in
Google Scholar
PubMed
Close
,
W J de Greef
Search for other papers by W J de Greef in
Google Scholar
PubMed
Close
, and
T J Visser
Search for other papers by T J Visser in
Google Scholar
PubMed
Close

Abstract

TRH-like peptides share the N- and C-terminal amino acids with TRH (pGlu-His-Pro-NH2) but differ in the middle amino acid residue. One of them, pGlu-Glu-Pro-NH2 (<EEP-NH2; EEP) is present in the rat pituitary gland, but its biological significance is unknown. We investigated the localization and regulation of this tripeptide in the rat pituitary gland. To distinguish between TRH and EEP two antisera were used for RIA: specificity of antiserum 4319 for the TRH-like peptides pGlu-Phe-Pro-NH2 and EEP was equal to or greater than that for TRH, whereas antiserum 8880 is TRH-specific. Our RIA data showed the presence of a TRH-like peptide in the anterior pituitary gland (AP) and of TRH in the posterior pituitary gland (PP). The TRH-like peptide in the AP was identified on anion-exchange chromatography and subsequent HPLC as EEP. Pathophysiological conditions such as altered thyroid and adrenal status and suckling did not affect pituitary gland levels of EEP. In general, however, there is a clear sex difference: levels of EEP are higher in male than in female rats. In both sexes gonadectomy leads to a substantial two- to threefold rise in EEP levels, abolishing the sex difference. Testosterone administration to gonadectomized male rats normalizes levels of EEP again. Disulfiram, an inhibitor of the enzyme peptidylglycine α-amidating monooxygenase, reduced levels of EEP in the AP by approximately 50%. In conclusion: 1) the TRH-like peptide EEP is present in the AP, whereas TRH is confined to the PP, 2) levels of EEP in the AP are regulated by sex steroids, 3) EEP is actively amidated in the AP and thus seems to be produced from a glycine-extended progenitor sequence.

Journal of Endocrinology (1995) 145, 43–49

Restricted access
G A C van Haasteren
Search for other papers by G A C van Haasteren in
Google Scholar
PubMed
Close
,
E Sleddens-Linkels
Search for other papers by E Sleddens-Linkels in
Google Scholar
PubMed
Close
,
H van Toor
Search for other papers by H van Toor in
Google Scholar
PubMed
Close
,
W Klootwijk
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Close
,
F H de Jong
Search for other papers by F H de Jong in
Google Scholar
PubMed
Close
,
T J Visser
Search for other papers by T J Visser in
Google Scholar
PubMed
Close
, and
W J de Greef
Search for other papers by W J de Greef in
Google Scholar
PubMed
Close

Abstract

We investigated the effects of diabetes mellitus on the hypothalamo-hypophysial-thyroid axis in male (R×U) F1 and R-Amsterdam rats, which were found to respond to streptozotocin (STZ)-induced diabetes mellitus with no or marked increases, respectively, in plasma corticosterone. Males received STZ (65 mg/kg i.v.) or vehicle, and were killed 1, 2 or 3 weeks later. At all times studied, STZ-induced diabetes mellitus resulted in reduced plasma TSH, thyroxine (T4) and 3,5,3′-tri-iodothyronine (T3). Since the dialyzable T4 fraction increased after STZ, probably as a result of decreased T4-binding prealbumin, plasma free T4 was not altered during diabetes. In contrast, both free T3 and its dialyzable fraction decreased during diabetes, which was associated with an increase in T4-binding globulin. Hepatic activity of type I deiodinase decreased and T4 UDP-glucuronyltransferase increased after STZ treatment. Thus, the lowered plasma T3 during diabetes may be due to decreased hepatic T4 to T3 conversion.

Median eminence content of TRH increased after STZ, suggesting that hypothalamic TRH release is reduced during diabetes and that this is not caused by impaired synthesis or axonal transport of TRH to the median eminence. Hypothalamic proTRH mRNA did not change in diabetic (R×U) F1 rats during the period of observation, but was lower in R-Amsterdam rats 3 weeks after STZ. Similarly, pituitary TSH and TSHβ mRNA had decreased in R-Amsterdam rats by 1 week after STZ treatment, but did not change in (R×U) F1 rats. The difference between the responses in diabetic R-Amsterdam and (R×U) F1 rats may be explained on the basis of plasma corticosterone levels which increased in R-Amsterdam rats only. Hypothalamic TRH content was not affected by diabetes mellitus, but the hypothalami of diabetic rats released less TRH in vitro than those of control rats. Moreover, insulin had a positive effect on TRH release in vitro.

In conclusion, the reduced hypothalamic TRH release during diabetes is probably not caused by decreases in TRH synthesis or transport to the median eminence, but seems to be due to impaired TRH release from the median eminence which may be related to the lack of insulin. Inhibition of proTRH and TSHβ gene expression in diabetic R-Amsterdam rats is not a primary event but appears to be secondary to enhanced adrenal activity in these animals during diabetes.

Journal of Endocrinology (1997) 153, 259–267

Restricted access
W Klootwijk
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Close
,
R D H de Boer
Search for other papers by R D H de Boer in
Google Scholar
PubMed
Close
,
E Sleddens-Linkels
Search for other papers by E Sleddens-Linkels in
Google Scholar
PubMed
Close
,
S M Cockle
Search for other papers by S M Cockle in
Google Scholar
PubMed
Close
,
W W de Herder
Search for other papers by W W de Herder in
Google Scholar
PubMed
Close
,
K Bauer
Search for other papers by K Bauer in
Google Scholar
PubMed
Close
,
T J Visser
Search for other papers by T J Visser in
Google Scholar
PubMed
Close
, and
W J de Greef
Search for other papers by W J de Greef in
Google Scholar
PubMed
Close

Abstract

TRH-like immunoreactivity (TRH-LI) was estimated in methanolic extracts of rat tissues and blood by RIA using antiserum 4319, which binds most peptides with the structure pGlu-X-ProNH2, or antiserum 8880, which is specific for TRH (pGlu-His-ProNH2). TRH-LI (determined with antiserum 4319) and TRH (determined with antiserum 8880) contents were 8 and 8 ng/g in brain, 216 and 222 ng/g in hypothalamus, 6·5 and 6 ng/g in pancreas, 163 and 116 ng/g in male pituitary, 105 and 77 ng/g in female pituitary, 1 and 0·1 ng/g in salivary gland, 61 and 42 ng/g in thyroid, 12 and 3 ng/g in adrenal, 3 and 0·3 ng/g in prostate, and 11 and 0·8 ng/g in ovary respectively. Blood TRH-LI (antiserum 4319) and TRH (antiserum 8880) levels were 31 and 18 pg/ml in male rats, and 23 and 10 pg/ml in female rats respectively. Unextracted serum obtained from blood kept for at least 1 h at room temperature no longer contained authentic TRH but still contained TRH-LI (males 20·3 ± 3·1, females 15·9 ± 3·0 pg/ml; means ± s.e.m.). Isocratic reverse-phase HPLC showed that TRH-LI in serum is largely pGlu-Glu-ProNH2 (<EEP-NH2), a peptide previously found in prostate and anterior pituitary.

In urine, TRH-LI (antiserum 4319) and TRH (antiserum 8880) levels were 3·21 ± 0·35 and 0·32 ± 0·04 ng/ml in male rats and 3·75 ± 0·22 and 0·37 ± 0·04 ng/ml in female rats respectively (means ± s.e.m.). Anion-exchange chromatography on QAE-Sephadex showed that urine of normally fed rats contains both basic/neutral TRH-LI (b/nTRH-LI) and acidic TRH-LI (aTRH-LI) in a ratio of ≈ 40:60, and further analysis by HPLC indicated that aTRH-LI represents <EEP-NH2. Analysis of food extracts and urine from fasted rats demonstrated that b/nTRH-LI is derived from food particles spilled by the rats during urine collection, while aTRH-LI is endogenously produced. While urinary aTRH-LI levels were higher in female than in male rats (2·99 ± 0·41 vs 2·04 ± 0·20 ng/ml), the daily urinary excretion was similar in both sexes (females 15·6 ± 1·4, males 19·5 ± 2·0 ng/day). Intravenously injected <EEP-NH2 disappeared from serum with a half-life of ≈ 1 h, and was recovered unchanged and quantitatively in urine. In contrast, when <EEP-NH2 was administered with food, only ≈ 0·5% was recovered in urine. The urinary clearance rate of serum TRH-LI amounted to 0·52 ± 0·10 ml/min in males and 0·34 ± 0·05 ml/min in females.

In view of the presence of <EEP-NH2 in the anterior pituitary gland, and the regulation of its content in parallel with gonadotrophins, we examined the possibility that serum <EEP-NH2 is of pituitary origin and correlates with gonadotrophin secretion. However, treatments that alter pituitary <EEP-NH2 content and gonadotrophin release had no effect on serum TRH-LI or urinary aTRH-LI.

In conclusion, the TRH-like peptide <EEP-NH2 is present in rat serum and is excreted into the urine. Moreover, <EEP-NH2 in serum and urine is not derived from rat food and is probably not of pituitary origin.

Journal of Endocrinology (1997) 153, 411–421

Restricted access
A. P. N. Themmen
Search for other papers by A. P. N. Themmen in
Google Scholar
PubMed
Close
,
R. Molenaar
Search for other papers by R. Molenaar in
Google Scholar
PubMed
Close
,
W. J. Visser
Search for other papers by W. J. Visser in
Google Scholar
PubMed
Close
,
J. F. Jongkind
Search for other papers by J. F. Jongkind in
Google Scholar
PubMed
Close
,
F. F. G. Rommerts
Search for other papers by F. F. G. Rommerts in
Google Scholar
PubMed
Close
, and
H. J. van der Molen
Search for other papers by H. J. van der Molen in
Google Scholar
PubMed
Close

ABSTRACT

The morphological and steroidogenic properties of preparations of interstitial cells isolated by collagenase treatment from testes of immature and mature rats have been compared.

After additional purification on a Ficoll gradient, 80% of cells from mature rat testes were found to be Leydig cells; 20% were macrophages. Forty to sixty per cent of collagenase-dispersed cells isolated from immature rats were Leydig cells, 37% were mesenchymal cells and there were no macrophages. A preparation in which 90% cells were Leydig cells could be obtained from immature testes after further purification by centrifugation through a Percoll gradient. The distribution of steroidogenic enzymes through the gradient corresponded to the distribution of LH-dependent steroid production. The results indicate that the steroidogenic activity per Leydig cell from mature rats is fourfold greater than the activity in immature rat Leydig cells in control incubations or after stimulation with LH, dibutyryl cyclic AMP or in the presence of 22R-hydroxycholesterol.

J. Endocr. (1987) 112, 361–366

Restricted access
G A C van Haasteren
Search for other papers by G A C van Haasteren in
Google Scholar
PubMed
Close
,
H van Toor
Search for other papers by H van Toor in
Google Scholar
PubMed
Close
,
W Klootwijk
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Close
,
B Handler
Search for other papers by B Handler in
Google Scholar
PubMed
Close
,
E Linkels
Search for other papers by E Linkels in
Google Scholar
PubMed
Close
,
P van der Schoot
Search for other papers by P van der Schoot in
Google Scholar
PubMed
Close
,
J van Ophemert
Search for other papers by J van Ophemert in
Google Scholar
PubMed
Close
,
F H de Jong
Search for other papers by F H de Jong in
Google Scholar
PubMed
Close
,
T J Visser
Search for other papers by T J Visser in
Google Scholar
PubMed
Close
, and
W J de Greef
Search for other papers by W J de Greef in
Google Scholar
PubMed
Close

Abstract

This study describes the effects of litter size and acute suckling on the synthesis and release of hypothalamic TRH, as indirectly estimated by determination of hypothalamic prothyrotrophin-releasing hormone (proTRH) mRNA and median eminence TRH content. The effects of litter size (five or ten pups) were studied throughout lactation, while suckling-induced acute changes were analyzed on day 13 of lactation in dams with ten pups. In view of the enhanced adrenal activity during lactation and recent evidence that corticosteroids have negative effects on hypothalamic TRH, we also studied adrenalectomized (ADX) dams treated with corticosterone to maintain basal plasma corticosterone levels.

In addition to an increased plasma level of prolactin (PRL), adrenal weight and plasma corticosterone increased, while plasma TSH, tri-iodothyronine (T3), thyroxine (T4) and free T4 (FT4) levels decreased during lactation. Litter size correlated positively with plasma PRL, adrenal weight and plasma corticosterone. No effect of litter size was observed on plasma T3, but rats with ten pups had lower plasma TSH, T4 and FT4 than rats with a five-pup litter. Compared with dioestrous rats, lactating rats showed an increased hypothalamic proTRH mRNA content on day 2, but not on days 8 and 15 of lactation. Median eminence TRH in lactating rats gradually increased until day 15 and decreased thereafter. Acute suckling, after a 6-h separation of mother and pups, rapidly increased plasma PRL and corticosterone in the mothers, but had no effects on plasma TSH and thyroid hormone levels. Hypothalamic proTRH mRNA increased twofold after 0·5 h of suckling, and then gradually returned to presuckling values after 6 h. Compared with sham-operated rats, corticosterone-substituted ADX rats with ten pups had increased plasma PRL and TSH, hypothalamic proTRH mRNA and pituitary TSH β mRNA on day 15 of lactation. Moreover, while acute suckling did not enhance TSH release in sham-operated rats, it provoked not only PRL but also TSH release in corticosterone-substituted ADX dams.

It is concluded that suckling exerts a rapid, positive effect on hypothalamic proTRH mRNA content. However, the concurrent enhanced adrenal activity has negative effects on hypothalamic proTRH gene expression resulting in a suppressed hypophysial-thyroid axis during lactation. While TRH appears to play a role in PRL release during the first days of lactation and during acute suckling, TRH seems not important in maintaining PRL secretion during continued suckling.

Journal of Endocrinology (1996) 148, 325–336

Restricted access
G A C van Haasteren
Search for other papers by G A C van Haasteren in
Google Scholar
PubMed
Close
,
E Linkels
Search for other papers by E Linkels in
Google Scholar
PubMed
Close
,
H van Toor
Search for other papers by H van Toor in
Google Scholar
PubMed
Close
,
W Klootwijk
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Close
,
E Kaptein
Search for other papers by E Kaptein in
Google Scholar
PubMed
Close
,
F H de Jong
Search for other papers by F H de Jong in
Google Scholar
PubMed
Close
,
M J Reymond
Search for other papers by M J Reymond in
Google Scholar
PubMed
Close
,
T J Visser
Search for other papers by T J Visser in
Google Scholar
PubMed
Close
, and
W J de Greef
Search for other papers by W J de Greef in
Google Scholar
PubMed
Close

Abstract

The reduced thyroid activity during short-term starvation is associated with a lowered hypothalamic synthesis and secretion of TRH. However, little is known about the cause of the reduced thyroid function during prolonged malnutrition. We have therefore studied the effects of food reduction to one-third of normal (FR33) on the hypothalamus-pituitary-thyroid axis of male and female Wistar rats. After 3 weeks body weights of FR33 rats were almost 50% lower than those of controls. In both sexes, FR33 caused marked increases in serum corticosterone, and decreases in serum TSH, thyroxine (T4), free T4, tri-iodothyronine (T3) and free T3. While the free T3 fraction (FFT3) in serum decreased, the free T4 fraction (FFT4) tended to increase. Electrophoretic analysis indicated that decreased FFT3 was correlated with an increased thyroxine-binding globulin, while the increase in FFT4 seemed due to a decreased thyroxine-binding prealbumin binding capacity. Total RNA and proTRH mRNA in the hypothalamus were not affected by FR33. Median eminence and posterior pituitary TRH content tended to increase in FR33 rats, suggesting that hypothalamic TRH release is reduced in FR33 rats. Anterior pituitary TSH content was decreased by FR33 in both sexes, but pituitary TSHβ mRNA and TRH receptor status were not affected except for increased pituitary TSHβ mRNA in female FR33 rats. Although FR33 had no effect on pituitary weight, pituitary RNA and membrane protein content in FR33 rats were 50–70% lower than values in controls.

In conclusion, prolonged food reduction suppresses the pituitary-thyroid axis in rats. In contrast to short-term food deprivation, the mechanism whereby serum TSH is suppressed does not appear to involve decreases in proTRH gene expression, but may include effects on pituitary mRNA translation. Our results further support the hypothesis that TSH release may be lowered by increased corticosterone secretion, although the mechanism of this effect may differ between acute starvation and prolonged food reduction.

Journal of Endocrinology (1996) 150, 169–178

Restricted access